Monday, June 13, 2016

Critical Reviews of India's National Intellectual Property Rights Policy, 2016

India's National Intellectual Property Rights Policy, 2016, receives mixed reactions from the policy analysts, activists, industry experts and scholars of innovation studies. Some of the observations are appeared in the following online articles:
  • National Intellectual Property Policy Suffers from a Lack of Conceptual Clarity. by Srividhya Ragavan, K. Subramanian | | June 11, 2016 | Download | The best aspects of the document are contained in the third objective discussing the legal and legislative framework.
  • Why New IPR Policy Is Inadequate: Pressure from US Is Unstated Reason. by K M Gopakumar | Economic and Political Weekly | 21 May, 2016 | Download | By proposing a maximalist approach towards intellectual property rights, the new IPR policy announced by the government is not tailored for India's socio-economic requirements.
  • National Intellectual Property Rights: Patently a Missed Opportunity. by Achal Prabhala & Sudhir Krishnaswamy | The Hindu | May 25, 2016 | Download
  • India's New IP Policy: A "Bare" Act? by Shamnad Basheer | |  June 6, 2016 | Download
  • Modi's New Intellectual Property Rights Policy Will Only Benefit Players with Deep Pockets. by Anubha Sinha | The Wire | May 21, 2016 | Download | The new policy fails to enact a balanced regime and instead is tilted in favour of rights-holders.
  • Why You Just Can't Have a One-Size-Fits-All IPR Policy. by Sushila Ravindranath | June 13, 2016 | Financial Express | Download | The National IPR (Intellectual Property Rights) policy was released on May 11. This 38-page document will give directions to the government to promote 'creative and innovative India'.
  • India Calls for Flexibilities in Intellectual Property Rights to Combat AIDS. by PTI | | June 10, 2016 | Download
  • Ahead of Prime Minister Modi's Visit, Doctors Without Borders Urges India to Put People's Health Before Pharmaceutical Profits. by | June 02, 2016 | Download | India must resist pressure from US lawmakers and pharmaceutical industry groups to block access to key medicines for millions of people worldwide.
  • At EU-India Summit, India Must Defend Its "Pharmacy of the Developing World". by | June 02, 2016 | Download | MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines.

  • Indian National Intellectual Property Rights Policy, 2016 | Department Of Industrial Policy & Promotion: Government of India | May 12, 2016 | Download

No comments: